The Project Orbis initiative is an international partnership between medicines regulators in the UK,...
Read moreCollectively, companies still owe AIFA €370 million of the €2.8 billion that industry has to rep...
Read moreABPI announces new VPAG, which focuses on restoring the commercially competitive environment for lif...
Read moreProject to help the EU develop new pricing and payment models to fund high-priced drugs and relieve ...
Read moreNew process to assess clinical and cost-effectiveness of COVID-19 treatments to get these medicines ...
Read moreSpain will ask pharmaceutical companies to submit their economic evaluation studies to reviewed late...
Read moreThe Federal Joint Committee (G-BA) has set out criteria for ATMPs which are likely to require qualit...
Read moreThe first adalimumab (branded Humira) biosimilar, Amjevita, has been launched in the US by pharmaceu...
Read moreNICE has recommended the first CAR T-cell therapy, Yescarta for the treatment of some lymphomas in a...
Read moreThe economic committee for health products (CEPs) have announced a price reduction of €67 that wil...
Read more